| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 40,761 | 29,976 | 25,910 | 35,149 | | Cost of Revenue | 25,040 | 17,758 | 16,079 | 21,578 | | | Gross Profit | 15,721 | 12,218 | 9,831 | 13,571 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,815 | 10,228 | 10,869 | 11,401 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,906 | 1,990 | (1,038) | 2,170 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (235) | (17) | (52) | (81) | | Earnings Before Interest And Taxes | 3,671 | 1,973 | (1,090) | 2,089 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 3,671 | 1,973 | (1,090) | 2,089 | | Income Tax Expense | 1,450 | 315 | (398) | 905 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,221 | 1,658 | (692) | 1,184 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,221 | 1,658 | (692) | 1,184 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,221 | $1,658 | ($692) | $1,184 |
|
1.00% Nasdaq 0.00%
Income Statement
